Transarterial Chemoembolization (TACE) Combined with Sorafenib versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study

Objective: To compare the outcomes of transarterial chemoembolization (TACE) combined with sorafenib versus TACE alone for treating patients with unresectable hepatocellular carcinoma (HCC). Methods: This retrospective analysis included all patients receiving either TACE plus sorafenib therapy or TA...

Full description

Saved in:
Bibliographic Details
Published in:J Cancer
Main Authors: Ren, Baosheng, Wang, Wansheng, Shen, Jian, Li, Wanci, Ni, Caifang, Zhu, Xiaoli
Format: Artigo
Language:Inglês
Published: Ivyspring International Publisher 2019
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400692/
https://ncbi.nlm.nih.gov/pubmed/30854128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.28994
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items